NCCS Cancer Fund

The NCCS Cancer Fund (previously known as the Community Cancer Fund) supports:

• financial assistance for needy patients;
• education and training of medical, nursing and paramedical professionals for better patient care and cancer prevention;
• development of cancer related publications for oncology professionals, patients and public; as well as
• improvements in infrastructure, equipment, facilities, processes and patient touch points for enhancement of patient care.

Since its inception in 1998, funds raised in a variety of ways provide support for specific cancer research and public education projects. The fund was renamed in year 2011 to better reflect its purpose with a strong focus on optimising patient care.

With your help, more lives can be touched as cancer affects 1 in 3 here. Financial assistance can help to diminish some distress that they experience from challenges that they may face along their cancer journey.

Non-financial Information

​FY2017 Year in Review	​FY2016 Year in Review	​FY2014-2015 Year in Review
​	​	​

(As the PDF file size is 1MB, it may take a few minutes to load.)

The NCCS Cancer Fund is a part of SingHealth Fund (SHF) – which was incorporated on 2 September 2016 as a Company Limited by Guarantee to operate charity funds for the SingHealth cluster. All donations to the NCCS Cancer Fund are ring-fenced under the SHF for NCCS Cancer Fund purposes and will be used in accordance with the donors’ intent for cancer causes. As an Institution of Public Character (IPC), SHF is committed to maintaining highest standards of governance and abides by the Code of Governance for Charities and IPCs.

Institution Fund Committee of NCCS Cancer Fund

​Chairperson            Madam Ho Geok Choo CEO, Human Capital (Singapore) Pte Ltd	​	​
​Members Mr George Thia Peng Heok Independent Director, Yoma Strategic Holdings Limited	​ Mr Kaka Singh Chairman and Senior Partner, RSM Chio Lim LLP	​ Mr Ng Boon Yew Chairman and CEO, Raffles Campus Pte Ltd
​ Prof Soo Khee Chee Surgeon, Soo Khee Chee Surgery	​ Prof Tan Ser Kiat Emeritus Consultant, Singapore General Hospital	​ Prof William Hwang  Senior Advisor, SingHealth, Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS), Senior Consultant, Department of Haematology, NCCS and SGH
​ Mr Harry Ng Executive Director, HLM (International) Corporate Services Pte. Ltd	​ Ms Bianca Cheo Hui Hsin Executive Director & Chief Operating Officer, Mewah International Inc.	​              Mr Vikna Rajah Head Tax & Trust, Co-head Private Wealth, Rajah & Tann Singapore LLP
​ Ms Lim Lei Theng Partner Allen & Gledhill LLP	​	​

Finance Advisory Panel

Chairman Mr Ng Boon Yew Chairman and CEO, Raffles Campus Pte Ltd
Members Mr Seow Choong Huei Founder, 8818 Enterprises Private Limited	Mr George Thia Peng Heok Independent Director, Yoma Strategic Holdings Limited

Audit Advisory Panel

Chairperson Mr Harry Ng Executive Director, HLM (International) Corporate Services Pte. Ltd
Members Mr Kaka Singh Chairman and Senior Partner, RSM Chio Lim LLP	Mr Khor Boon Hong Partner, Baker Tilly TFW LLP

Development and Advocacy Advisory Panel

Chairperson Ms Bianca Cheo Hui Hsin Executive Director & Chief Operating Officer, Mewah International Inc.
Members Ms Sharon Au Investment Director, Jolt Capital	Ms He Jihong CEO,  International Business Huazhu Group	Ms Fiona Leung Managing Partner, Olive Vista Capital
Dr Tay Miah Hiang Senior Consultant  Medical Oncologist OncoCare Cancer Centre	Mr Cayden Chang  Founder, Value Investing Academy (VIA)

Nomination Sub-committee

Chairperson Prof William Hwang  Senior Advisor, SingHealth, Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS), Senior Consultant, Department of Haematology, NCCS and SGH
Members Prof Tan Ser Kiat Emeritus Consultant, Singapore General Hospital	Ms Shoba Gunasekaran District Manager, H&R Block Limited (Australia)	Mr Perry Lim Executive Director, Royal Golden Eagle
Madam Ho Geok Choo CEO, Human Capital (Singapore) Pte Ltd

Auditor

Ernst & Young